LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 5 von insgesamt 5

Suchoptionen

  1. Artikel ; Online: Usefulness of teledermatology in prisons. The experience in the Penitentiary Center Castellón II.

    Pitarch-Bort, Gerard / Arnandis-Viñerta, Oreto / Herrero-Matías, Agustín Mª

    Revista espanola de sanidad penitenciaria

    2023  Band 25, Heft 1, Seite(n) 16–19

    Abstract: Introduction: Teledermatology is the application of new technologies for the care of skin diseases. Its application in prisons allows the diagnosis and treatment of prisoners without the need to transfer them to the hospital, avoiding the problems ... ...

    Abstract Introduction: Teledermatology is the application of new technologies for the care of skin diseases. Its application in prisons allows the diagnosis and treatment of prisoners without the need to transfer them to the hospital, avoiding the problems associated with travel.
    Material and method: The objective of this work is to analyze the usefulness of teledermatology in prisons, through a retrospective observational study in the Castellón II-Albocàsser penitentiary.
    Results: The study sample consisted of 37 patients and 43 interconsultations. All the consultations corresponded to men, with a mean age of 42.43 years. 95.3% of the consultations were asynchronous and in 86% of them a diagnosis and a complete treatment plan were established. Only 18.6% of the consultations required a face-to-face consultation.
    Discussion: It is concluded that teledermatology in prisons is effective in the care and resolution of dermatological problems.
    Mesh-Begriff(e) Male ; Humans ; Adult ; Prisons ; Dermatology ; Remote Consultation ; Skin Diseases/diagnosis ; Skin Diseases/therapy ; Prisoners ; Telemedicine
    Sprache Englisch
    Erscheinungsdatum 2023-06-19
    Erscheinungsland Spain
    Dokumenttyp Observational Study ; Journal Article
    ZDB-ID 2424262-7
    ISSN 2013-6463 ; 2013-6463
    ISSN (online) 2013-6463
    ISSN 2013-6463
    DOI 10.18176/resp.00062
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: Hospital de Campaña de Castellón: análisis integral de su uso durante la pandemia por SARS-CoV-2.

    González Bonet, Luis Germán / García-Martínez, José / Tornador Gaya, Nuria / Guadalajara Saez, Adoración / Pitarch-Bort, Gerard

    Revista espanola de salud publica

    2023  Band 97

    Abstract: Objective: Field hospitals, also known as alternative care sites, have been an important healthcare reinforcement during the SARS-CoV-2 pandemic worldwide. In the Valencian Community, three of these hospitals were opened, one for each province. Our ... ...

    Titelübersetzung Castellón Field Hospital: comprehensive analysis of its use during the SARS-CoV-2 pandemic.
    Abstract Objective: Field hospitals, also known as alternative care sites, have been an important healthcare reinforcement during the SARS-CoV-2 pandemic worldwide. In the Valencian Community, three of these hospitals were opened, one for each province. Our study aimed to make a comprehensive analysis of this resource in Castellon.
    Methods: A retrospective observational study was carried out with an analytical and statistical component of 3 aspects: infrastructure, satisfaction and clinical data from COVID-positive hospitalized patients. The sources of information were primary, institutional for the infrastructure and personal for the satisfaction surveys and clinical data.
    Results: A set of 6x3 metres polyvalent tents was chosen, which joined formed a single-floor area of about 3.500 m
    Conclusions: This is one of the few studies in the literature in which a field hospital is analyzed from such different points of view. After this analysis, it is concluded that it is an extraordinary and temporary resource whose use is useful without reflecting an increase of morbidity/mortality among our patients and with a very favorable subjective assessment.
    Mesh-Begriff(e) Humans ; Middle Aged ; COVID-19/epidemiology ; Mobile Health Units ; Oxygen/therapeutic use ; Pandemics ; SARS-CoV-2 ; Spain/epidemiology ; Retrospective Studies
    Chemische Substanzen Oxygen (S88TT14065)
    Sprache Spanisch
    Erscheinungsdatum 2023-05-17
    Erscheinungsland Spain
    Dokumenttyp Observational Study ; English Abstract ; Journal Article
    ZDB-ID 1288657-9
    ISSN 2173-9110 ; 0034-8899 ; 1135-5727
    ISSN (online) 2173-9110
    ISSN 0034-8899 ; 1135-5727
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 483: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  3. Artikel ; Online: Queratoconjuntivitis asociada a dermatitis atópica tratada con tocilizumab.

    Raga Jiménez, Celia / Álvarez Martín, Tamara / Ferrando Piqueres, Raúl / Pitarch Bort, Gerard

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

    2018  Band 42, Heft 1, Seite(n) 29–30

    Titelübersetzung Keratoconjunctivitis associated with atopic dermatitis treated with tocilizumab.
    Mesh-Begriff(e) Adrenal Cortex Hormones/therapeutic use ; Adult ; Antibodies, Monoclonal, Humanized/therapeutic use ; Blindness/etiology ; Cyclosporine/therapeutic use ; Dermatitis, Atopic/complications ; Dermatitis, Atopic/drug therapy ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Keratoconjunctivitis/complications ; Keratoconjunctivitis/drug therapy ; Off-Label Use
    Chemische Substanzen Adrenal Cortex Hormones ; Antibodies, Monoclonal, Humanized ; Immunosuppressive Agents ; Cyclosporine (83HN0GTJ6D) ; tocilizumab (I031V2H011)
    Sprache Spanisch
    Erscheinungsdatum 2018-01-01
    Erscheinungsland Spain
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 1122680-8
    ISSN 2171-8695 ; 1130-6343
    ISSN (online) 2171-8695
    ISSN 1130-6343
    DOI 10.7399/fh.10885
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 3450: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  4. Artikel ; Online: A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients.

    Ortiz-Salvador, José-María / Saneleuterio-Temporal, Martina / Magdaleno-Tapial, Jorge / Velasco-Pastor, Manel / Pujol-Marco, Conrad / Sahuquillo-Torralba, Antonio / Mateu-Puchades, Almudena / Pitarch-Bort, Gerard / Marí-Ruiz, Juan-Ignacio / Mataix-Díaz, Javier / Montesinos-Villaescusa, Encarna / Miralles-Botella, Julia / García-Fernández, Laura / Martorell-Calatayud, Antonio / Belinchón-Romero, Isabel / Sánchez-Carazo, José-Luis / Pérez-Ferriols, Amparo

    Journal of the American Academy of Dermatology

    2019  Band 81, Heft 2, Seite(n) 427–432

    Abstract: Background: Secukinumab is a first-in-class interleukin 17A monoclonal antibody that has demonstrated an excellent safety and efficacy profile in phase 3 studies.: Objective: To evaluate the effectiveness of secukinumab in daily clinical practice and ...

    Abstract Background: Secukinumab is a first-in-class interleukin 17A monoclonal antibody that has demonstrated an excellent safety and efficacy profile in phase 3 studies.
    Objective: To evaluate the effectiveness of secukinumab in daily clinical practice and to understand the clinical and epidemiologic characteristics of patients treated with secukinumab in clinical settings.
    Methods: In this multicenter prospective observational study, we recruited adult patients with moderate-to-severe plaque psoriasis from 12 hospitals in Spain during January-December 2016. These patients were treated with secukinumab and prospectively followed at 12-week intervals for 52 weeks.
    Results: In total, 158 patients were recruited to the study. A Psoriasis Area and Severity Index (PASI) score improvement ≥75% over baseline (PASI-75) was achieved by 57%, 83.5%, 89%, and 78.5% of patients at weeks 4, 12, 24, and 52, respectively. PASI-90 was achieved in 27.8%, 62%, 64.6%, and 63.2% of patients at weeks 4, 12, 24, and 52, respectively; PASI-75 and PASI-90 responders were significantly more common among patients with a body mass index <30 kg/cm
    Limitations: Observational study. Time from onset of psoriasis was not evaluated.
    Conclusion: Secukinumab is a safe treatment with effectiveness rates similar to those found in its phase 3 studies. These rates endure up to a year from start of treatment.
    Mesh-Begriff(e) Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Body Mass Index ; Dermatologic Agents/adverse effects ; Dermatologic Agents/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Psoriasis/drug therapy ; Severity of Illness Index ; Treatment Outcome
    Chemische Substanzen Antibodies, Monoclonal, Humanized ; Dermatologic Agents ; secukinumab (DLG4EML025)
    Sprache Englisch
    Erscheinungsdatum 2019-03-11
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2019.02.062
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 1540: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  5. Artikel: Treatment of protein contact dermatitis with topical tacrolimus.

    Mercader, Pedro / de la Cuadra-Oyanguren, Jesús / Rodríguez-Serna, Mercedes / Pitarch-Bort, Gerard / Fortea-Baixauli, Jose Miguel

    Acta dermato-venereologica

    2005  Band 85, Heft 6, Seite(n) 555–556

    Mesh-Begriff(e) Administration, Topical ; Adult ; Dermatitis, Allergic Contact/drug therapy ; Dermatitis, Allergic Contact/etiology ; Dermatitis, Occupational/drug therapy ; Dermatitis, Occupational/etiology ; Female ; Food Handling ; Humans ; Immunosuppressive Agents/administration & dosage ; Proteins/immunology ; Tacrolimus/administration & dosage
    Chemische Substanzen Immunosuppressive Agents ; Proteins ; Tacrolimus (WM0HAQ4WNM)
    Sprache Englisch
    Erscheinungsdatum 2005
    Erscheinungsland Sweden
    Dokumenttyp Case Reports ; Letter
    ZDB-ID 80007-7
    ISSN 1651-2057 ; 0001-5555
    ISSN (online) 1651-2057
    ISSN 0001-5555
    DOI 10.1080/00015550510037693
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Ui VI Zs.101: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang